Latest Breaking News On - Lucie larguier - Page 8 : comparemela.com

Transgene to Present Data on its Two Therapeutic Cancer Vaccines at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Transgene to Present Data on its Two Therapeutic Cancer Vaccines at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTransgene euronextLucie larguierAmerican association of clinical oncologyCorporate communicationsEuronext parisClinical oncologyDevelopmental therapeuticsNeck cancerArtificial intelligenceRisk factorsUniversal registration document

Transgene and BioInvent Report Positive Phase Ia Data on Oncolytic Virus BT-001 in Solid Tumors

Transgene and BioInvent Report Positive Phase Ia Data on Oncolytic Virus BT-001 in Solid Tumors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Martin welschofAlessandro rivaSylvie berrebiCecilia hofvanderLucie larguierTransgene euronextSafety review committeeBioinvent internationalMerck coBioinvent international ab nasdaq stockholmCorporate communicationsWall streetEuronext parisNasdaq stockholmArtificial intelligenceRisk factors

Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered Intravenously, in Non-Small Cell Lung Cancer

TG6050 is an oncolytic virus derived from Transgene's Invir.IO® platform encoding interleukin-12 (IL-12) and an anti-CTLA4 antibody, with the potential to trigger a powerful antitumor immune response.

United statesMaud brandelyLucie larguierSylvie berrebiTransgene euronextAmerican association for cancer researchCorporate communicationsPhasei delivirEuronext parisChief medical officerAmerican associationCancer researchAnnual meetingArtificial intelligenceRisk factorsUniversal registration document

Transgene : Inside Information / Other news releases

P R E S S R E L E A S E Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered. | May 10, 2023

United statesMaud brandelyTransgene euronextSylvie berrebiLucie larguierCorporate communicationsAmerican association for cancer researchPatient dosedPhasei trial evaluatingArmed oncolytic virus administered intravenouslyNon small cell lung cancerPhasei delivirEuronext parisChief medical officerAmerican associationCancer research

Transgene provides business update and Q1 2023 financial position

Transgene provides business update and Q1 2023 financial position
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pedro romeroAlessandro rivaChristian ottensmeierCarol stuckleyBen brahimJohnc bellLucie larguierTransgene euronextCorporate communicationsCompany board of directorsJolla institute for immunologyMerck coUniversity of liverpoolEuronext parisProfessor christian ottensmeierTasly biopharmaceuticals